World News Insights
1-3 Minute Gist

Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.

Xi Jinping Tariff Negotiating Strategy with US Articles

LyrArc brings in selected articles from many of the world's top publications.

Articles are selected by experts and you can see the gist of the important articles.


Economist Original article ›
LyrArc Article Gist
Conde Nast, Hearst, Meredith which publishes Better Homes and Gardens, News Corporation, and Time inc. have joined together to develop software that would create digital publications for iphones, e-readers, and arange of devices. The idea is to have astorefront much like Apple's iTunes. Individually these companies are also working on digital software. Conde nast is working with Adobe to develop software for advanced e-readers. Hearst has astartup called Skiff. Media companies already own sakes in Hulu which streams television programmes from three of America's four English language broadcasters.
Economist Original article ›
Economist Original article ›
Economist Original article ›
Economist Original article ›
Economist Original article ›
LyrArc Article Gist
Is Toyota in decline? In the first quarter of 2009 Toyota suffered ahuge loss comparable to GM's. Toyota's CEO, Mr Toyoda, thinks it is in decline. And having read Jim Collins book "How the Mighty Fall", Toyoda thinks Toyota is already at the fourth stage of decline in the five stages Collins has outlined. Collins looks at the traumatic steps before IBM, HP reemerged from crisis and How Motorola failed to emerge. Same is true for Apple. Success at something is now guarantee of continuation, infact at the point of everything going well things are already in place to cause the rapid decline.

Back to the lab

Economist Original article ›
LyrArc Article Gist
The new head of Roche, Severin Schwan, sees a huge opportunity in the current state of pharmaceuticals. He says drugmaking is still "so crude," because half of all known diseases cannot be treated at all, and the drugs for the diseases that are being treated don't work as well as they should and with a lot of side effects that make serious drawbacks in using them. He compares this state of affairs to acar that starts only half of the time and has brakes that don't always work. What gets hime excited is the rapid advances in diagnostics, genomics and biotechnology that can bring a"brand new revolution" in personalized medicine. He is pushing forward in the areas of biotechnology with the $47 billion deal that integrates Genentech into Roche, and in molecular diagnostics with the integration of 454 Life Sciences and Ventana. Doubts were raised during the integration of Genentech into Roche about whether the research climate at Genentech could be preserved and whether research scinetists would leave. But most have stayed. With the resources of a larger company behind Genentech and the patient approach that a firm with a founding family controlling the firm can take under a leadership determined to invest in research, experts like Tim Anderson of Bernstein Research see Roche well positioned to grow by aquarter over the next five years....
Wall Street Journal Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
LyrArc Article Gist
On December 10, 2009, after insisting for months that they would go ahead with the bonuses at Goldman Sachs, and with public opinion increasingly turning against Goldman, Blankfein decides to hold back the bonuses. This was after the British government had announced a decision to tax 2009 bank bonuses at 50% and pressure was building for the US to also to tax bonuses and limit executive pay.
Wall Street Journal Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
LyrArc Article Gist
This story is how hedge fund traders make money by buying credit default swaps for default protection on the debt of countries with huge debts. These countries are called by hedge fund traders as "the piigs" and money is to be made by buying these credit default swaps on countries when they are selling for less. As ripples appear such as the Dubai debt crisis and markets get nervous the protection prices rise making the credit defaults cost more. The countries where these traders expect problems are Greece, Ireland, Spain, Portugal and Italy. These investors take risks as these bearish positions were not reflected in economic conditions as confidence returned in 2009, but the longer term picture is fairly clear for these countries. Hedge funds doing this are Balestra Capital, Hayman Capital and North Asset Management, Pivot Capital Management.
Wall Street Journal Original article ›

Support LyrArc

We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.

Support Lyrarc from as small as $1


Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us